The Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2024 were officially signed into law on 10 April 2025, marking a significant development in the UK clinical trials framework ...

While the US Food and Drug Administration has been experiencing recent reorganization and cuts in personnel, the United ...

The progress the UK has made as a global contributor to clinical trials is “remarkable”, says Lord James O’Shaughnessy, former health minister and author of the landmark report into the ...

The first-ever analysis of the UK clinical trial landscape by the Medicines and Healthcare products Regulatory Agency (MHRA) and the University of Liverpool reveals the UK is a global leader in ...

The UK experienced a notable increase in advanced therapy clinical trials in 2024, reaching 187 ongoing trials. This marks a 7% rise from the previous year. Particularly, phase I trials saw an ...